ANTIBIOTIC THERAPY

Diarrhoea and preadmission antibiotic exposure in COVID-19: a retrospective cohort study of 1153 hospitalised patients
Bilal Akhter Mateen, Sandip Samanta, Sebastian Tullie, Sarah O’Neill, Zillah Cargill, Gillian Kelly, Ewen Brennan, Mehul Patel, Mohammad Al-Agil, James Galloway, James Teo, Debbie L Shawcross, Alexandra J Kent, Bu'Hussain Hayee

BMJ Open Gastroenterology Sep 2021, 8 (1) e000593; DOI: 10.1136/bmjgast-2020-000593
Changes in the gut microbiota composition and the plasma ghrelin level in patients with Helicobacter pylori-infected patients with eradication therapy
Hidetaka Yanagi, Ayumi Tsuda, Masashi Matsushima, Shunsuke Takahashi, Genki Ozawa, Yasuhiro Koga, Atsushi Takagi

BMJ Open Gastroenterology Nov 2017, 4 (1) e000182; DOI: 10.1136/bmjgast-2017-000182
Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review
Gurpartap S Sidhu, Andrew Go, Bashar M Attar, Hemant R Mutneja, Shilpa Arora, Sanjay A Patel

BMJ Open Gastroenterology Jul 2017, 4 (1) e000154; DOI: 10.1136/bmjgast-2017-000154
Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination
Lise Tornvig Erikstrup, Mie Aarup, Rikke Hagemann-Madsen, Frederik Dagnaes-Hansen, Brian Kristensen, Katharina Elisabeth Pribil Olsen, Kurt Fuursted

BMJ Open Gastroenterology Dec 2015, 2 (1) e000038; DOI: 10.1136/bmjgast-2015-000038
The common prophylactic therapy for bowel surgery is ineffective for clearing Bacteroidetes, the primary inducers of systemic inflammation, and causes faster death in response to intestinal barrier damage in mice
Daniel Sinsimer, Amira Esseghir, May Tang, Amale Laouar

BMJ Open Gastroenterology Jan 2014, 1 (1) e000009; DOI: 10.1136/bmjgast-2014-000009

Log in using your username and password

Main menu

Log in using your username and password

You are here

ANTIBIOTIC THERAPY